Investor Roadmap

Full name of the company

FreBor, production unitary enterprise

Year of establishment

1991

Primary activity

Production of medical products

Products, services description (detailed, indicating CN FEA code)

Dialysis products Gastric tubes, catheters, drainage devices Obstetrics and gynecology Polymeric medical connectors

Superior body

The Pharmaceutical Holdings Company "Belpharmprom"

General reference and analytical information about the company

Production unitary enterprise FreBor is the only one manufacturer of dialysis products on the territory of CIS states, a leading manufacturer of medical devices on the territory of the Republic of Belarus. The enterprise focuses on the production of disposable medical devices: dialyzers, dialysis needles, universal transfusion-infusion medical sets and other products. The main selling markets of products manufactured by the company are following: Republic of Belarus, Russian Federation, Republic of Azerbaijan, Ukraine, Republic of Armenia, and Republic of Uzbekistan.

Number of employees as on the month of filling the form, people

429

Type of investment project

Investment projects offered for implementation

Total volume of investments, thousand $

11000

Expected input of an investor, thousand $

8000

Project period

2022-2027

Investor participation form

equity investment, new enterprise with a local partner, new enterprise

Project description

Creation of a center with a complex radiation sterilization system

The nomenclature of the product to be produced with indication of the CN FEA code

Provision of services for radiation sterilization of medical devices, pharmaceuticals and food products

Simple pay-back period, yrs

6

Dymanic pay-back period, yrs

6

Potential customer

Pharmaceutics. Medical products. Food industry.

Key benefits of the project

The main differences of the proposed project from competing centers in the market for sterilization by the radiation method and making it unique: - the absence of similar industries in the Republic of Belarus; - high degree of inactivation of microorganisms; - the possibility of sterilization of large-sized medical devices in large volumes; - process automation; - after the sterilization process, tools, devices and materials do not contain carcinogenic substances; - sterilization is subject to medical products in their original packaging, in which the product is delivered to consumers; - products sterilized by the radiation method can be used immediately after the disinfection procedure; - during sterilization, the products do not come into contact with the external environment, which means that they do not change their properties; - high performance and efficiency of processing

Level of project development

Carrying out marketing research, developing a feasibility study